The Latest Cardiac and Vascular News
BOSTON–(BUSINESS WIRE)–Care Access, a global clinical research company helping to accelerate the future of medicine, is joining the National Lipid Association (NLA) Industry Council. The collaboration aims to enable more community-based lipidologists to participate in clinical research and create access to cardiometabolic trials for their patients. “Partnering with the NLA […]
Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billion Organic net sales increased 11.4% Reported operating income margin of 21.6% Adjusted operating income margin(1) increased 60 […]
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, […]
LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that it has closed a private placement (the “private placement” or the “financing”) resulting in gross proceeds of approximately $6.1 million, before deducting […]
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of Chuck Alpuche as Chief Operating Officer (COO), Peter Griffin as Senior Vice President of Operations, Scott Elliott as Chief Legal Officer (CLO), […]
The funds raised represent 110% of the Initial Offer; the net amount of €14.9 million will contribute to the Company’s short-term financing Together, demand and underwriting and guarantee commitments reached €18.8 million and were allocated as follows: €9.2 million as part of the global offering, including €7.8 million in subscription […]
January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 plan Agrees with FDA on terms of consent decree focused on Philips Respironics in the US, providing clarity and a roadmap to demonstrate compliance and to restore […]
SCOTTSDALE, Ariz., Jan. 25, 2024 (GLOBE NEWSWIRE) — Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to invest more than $50 million over the next several years in ATI’s Nitinol melt and materials conversion infrastructure. With this significant investment, which will more than triple ATI’s melt capacity […]
DARIEN, Conn. & BURLINGTON, Mass.–(BUSINESS WIRE)–The Vascular Care Group (“TVCG”) and Mangrove Management Partners (“Mangrove”, the affiliated management company of TVCG), announced today that Dr. Paul Gagne, will assume an expanded leadership role as Chief of Clinical Operations and Research. In this capacity, Dr. Paul Gagne will further lead and […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Art Taylor has been appointed to the Endologix Board of Directors. “Art’s wide-ranging experience in the healthcare sector adds a remarkable depth […]
